Download PDF
Thromb Haemost 1993; 69(03): 282-285
DOI: 10.1055/s-0038-1651596
Original Article
Platelets
Schattauer GmbH Stuttgart

Platelet Factor XIII Becomes Active without the Release of Activation Peptide during Platelet Activation

László Muszbek
The Department of Clinical Chemistry, Debrecen, Hungary
,
János Polgár
The Department of Clinical Chemistry, Debrecen, Hungary
,
Zoltán Boda
1   IInd Department of Medicine, University School of Medicine, Debrecen, Hungary
› Author Affiliations
Further Information

Publication History

Received 14 August 1992

Accepted after revision 16 November 1992

Publication Date:
05 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints

Summary

The potentially active A subunit of factor XIII of blood coagulation has also been detected in platelets and monocytes/macrophages though the exact function of this cellular protransglutaminase has not yet been elucidated. In physiological conditions the first step in the activation of plasma factor XIII is the removal of an activation peptide from the N-terminal end of subunit A by thrombin. The A subunit then, in the presence of Ca2+, dissociates from the inhibitory B subunit and assumes an active conformation. Cellular factor XIII, which lacks B subunit, can be proteolytically activated in vitro by thrombin and the intracellular Ca2+ sensitive protease, calpain, in the same way as plasma factor XIII subunit A, and calpain has been suggested as the intracellular protease involved in the activation of cellular factor XIII in platelets. In the present experiments it was shown by SDS PAGE that during long-term stimulation of platelets with thrombin nondisulfide-crosslinked high M r protein polymers not penetrating the concentrating gel were formed. The lack of these polymers in thrombin-stimulated factor XIII deficient platelets clearly indicated that their formation in normal platelets was due to factor XIII that became active during platelet activation. However, no release of the activation peptide could be detected by Western blotting during this process. Similarly, no proteolytic cleavage of factor XIII was detectable when platelets were stimulated by Ca2+ ionophore through this stimulus activated calpain as it was clearly demonstrated by the breakdown of major intracellular calpain substrates. The results indicate: 1) during thrombin induced platelet activation factor XIII becomes active and crosslinks platelet protein, 2) platelet factor XIII is not an intracellular substrate of calpain, 3) cellular factor XIII could be activated without the proteolytic removal of activation peptide. It is presumed that the nonproteolytic pathway for the activation of cellular factor XIII, we reported most recently, might have physiological implications under such conditions.

 

  • References

  • 1 Muszbek L, Laki K. Interaction of thrombin with proteins other than fibrinogen (thrombin susceptible bonds). Activation of factor XIII. In: Thrombin. Machovich R. (ed). CRC Press; Boca Raton, CA: 1984: 83-102
    Google Scholar
  • 2 McDonagh J. Structure and function of factor XIII. In: Hemostasis and Thrombosis. 2.. Colman RW, Hirsh J, Marder WJ, Salzman EW. (eds). Lippincott; Philadelphia, PA: 1987: 289-300
    Google Scholar
  • 3 Buluk K. An unknown function of blood platelets. Pol Tyg Lek 1955; 10: 191
    PubMedGoogle Scholar
  • 4 Lüscher EF. Ein fibrinstabilisierender Faktor aus Thrombozyten. Schweiz Med Wochensch 1957; 87: 1220-1221
    PubMedGoogle Scholar
  • 5 Muszbek L, Ádány R, Szegedi G, Polgár J, Kavai M. FXIII of blood coagulation in human monocytes. Thromb Res 1985; 37: 401-410
    CrossrefPubMedGoogle Scholar
  • 6 Ádány R, Belkin A, Vasilevskaya T, Muszbek L. Identification of blood coagulation factor XIII in human peritoneal macrophages. Eur J Cell Biol 1985; 38: 171-173
    PubMedGoogle Scholar
  • 7 Henriksson P, Becker S, Lynch G, McDonagh J. Identification of intracellular factor XIII in human monocytes and macrophages. J Clin Invest 1985; 76: 528-534
    CrossrefPubMedGoogle Scholar
  • 8 Áány R, Glukhova MA, Kabakov AY, Muszbek L. Characterization of human connective tissue cells containing factor XIII subunit a. J Clin Pathol 1987; 41: 49-56
    PubMedGoogle Scholar
  • 9 Cohen I, Glaser T, Veis A, Brunner-Lorand J. Ca2+ dependent crosslinking processes in human platelets. Biochim Biophys Acta 1981; 676: 137-147
    CrossrefPubMedGoogle Scholar
  • 10 Cohen I, Lim CT, Kahn DR, Glaser T, Gerrard JM, White JG. Disulfide-linked and transglutaminase-catalyzed protein assemblies in platelets. Blood 1985; 66: 143-151
    PubMedGoogle Scholar
  • 11 Ando Y, Imamura S, Yamagata Y, Kitahara A, Saji H, Murachi T, Kannagi R. Platelet factor XIII is activated by calpain. Biochem Biophys Res Commun 1987; 144: 484-490
    CrossrefPubMedGoogle Scholar
  • 12 Massini P, Käser-Glanzmann R, Lüscher EF. Movement of calcium ions and their role in the activation of platelets. Thromb Haemostas 1978; 40: 212-218
    PubMedGoogle Scholar
  • 13 Gerard JM. Calcium translocations. In: Platelet Responses and Metabolism. Vol III Holmsen H. (ed). CRC Press; Boca Raton, CA: 1986: 5-29
    Google Scholar
  • 14 Hawiger J, Steer ML, Salzman EW. Intracellular regulatory processes in platelets. In: Hemostasis and Thrombosis. 2. Colman RW, Hirsh J, Marder VJ, Salzman EW. (eds). Lippincott; Philadelphia: 1987: 710-725
    Google Scholar
  • 15 Bohn H, Schwick HG. Isolierung und Charakterisierung eines fibrin-stabilisierenden Faktors aus menschlichen Plazenten. Arzneim Forsch 1971; 21: 1432-1439
    PubMedGoogle Scholar
  • 16 Polgár J, Hidasi V, Muszbek L. Non-proteolytic activation of cellular protransglutaminase (placental macrophage factor XIII). Biochem J 1990; 267: 557-560
    CrossrefPubMedGoogle Scholar
  • 17 McDonagh J, Waggoner WG, Hamilton EG, Hindenach B, McDonagh RP. Affinity chromatography of human plasma and platelet factor XIII on organomercurial agarose. Biochim Biophys Acta 1976; 446: 345-357
    CrossrefPubMedGoogle Scholar
  • 18 Muszbek L, Laposata M. Covalent modification of platelet proteins by palmitate. Blood 1989; 74: 1339-1347
    PubMedGoogle Scholar
  • 19 Boda Z, Pfliegler G, Muszbek L, Tóth A, Ádány R, Hársfalvi J, Papp Z, Tornai I, Rák K. Congenital factor XIII deficiency with multiple benign breast tumours and successful pregnancy with substitutive therapy. Haemostasis 1989; 19: 348-352
    PubMedGoogle Scholar
  • 20 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4 . Nature 1970; 227: 680-682
    CrossrefPubMedGoogle Scholar
  • 21 Hársfalvi J, Fésüs L, Tarcsa E, Laczkó J, Loewy AG. The presence of a covalently cross-linked matrix in human platelets. Biochim Biophys Acta 1991; 1073: 268-274
    CrossrefPubMedGoogle Scholar
  • 22 Muszbek L, Ádány R, Kávai M, Boda Z, Lopaciuk S. Monocytes of patients congenitally deficient in plasma factor XIII lack factor XIII subunit A antigen and transglutaminase activity. Thromb Haemostas 1988; 59: 231-235
    PubMedGoogle Scholar
  • 23 Philips DR, Jakabova M. Ca2+-dependent protease in human platelets. Specific cleavage of platelet polypeptides in the presence of added Ca2+ . J Biol Chem 1977; 252: 5602-5605
    PubMedGoogle Scholar
  • 24 White GC. Calcium dependent proteins in platelets. Response of calcium-activated protease in normal and thrombasthenic platelets to aggregating agents. Biochim Biophys Acta 1980; 631: 130-138
    CrossrefPubMedGoogle Scholar
  • 25 Fox JEB, Reynolds CC, Philips DR. Calcium-dependent proteolysis occurs during platelet aggregation. J Biol Chem 1983; 258: 9973-9981
    PubMedGoogle Scholar
  • 26 Credo RB, Curtis CG, Lorand L. Ca2+-related regulatory function of fibrinogen. Proc Natl Acad Sci USA 1978; 75: 4234-4237
    CrossrefPubMedGoogle Scholar
  • 27 Lorand L. Activation of blood coagulation factor XIII. Ann NY Acad Sci 1986; 485: 144-158
    CrossrefPubMedGoogle Scholar